A Canadian research team suggests widely used ACE inhibitors may carry a very small risk of lung cancer, highlighting the importance of doctors clearly explaining risks versus benefits for their patients when medication study results are released.
A Canadian research team suggests widely used ACE inhibitors may carry a very small risk of lung cancer, highlighting the importance of doctors clearly explaining risks versus benefits for their patients when medication study results are released.